# Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke

> **NCT04287881** · NA · COMPLETED · sponsor: **Istanbul Medeniyet University** · enrollment: 32 (actual)

## Conditions studied

- Hyperhomocysteinemia, Thrombotic, Cbs-Related
- Ischemic Stroke
- Epilepsy

## Interventions

- **GENETIC:** Methylenetetrahydrofolate reductase (MTHFR) deficiency

## Key facts

- **NCT ID:** NCT04287881
- **Lead sponsor:** Istanbul Medeniyet University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-31
- **Primary completion:** 2020-02-15
- **Final completion:** 2020-02-20
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04287881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04287881, "Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04287881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*